Solanbridge Group Announces Reseller Agreement With Vega Biofuels
SLNX to market Biochar in Canada, Jamaica, and South Central Asia
Houston, TX / ACCESSWIRE / December 4, 2014 / Solanbridge Group Inc (OTC: SLNX) is pleased to announce that it has signed a Reseller Agreement with Georgia-based Vega BioFuels, Inc (OTC: VGPR) where Solanbridge has the opportunity to market Vega's Biochar product to its clients worldwide.
Vega's Biochar product is a highly absorbent specially designed charcoal-type product that among other things can be used as a soil enhancement for the agricultural industry to significantly increase crop yields. The Company's Biochar offers a powerfully simple solution to some of today's most urgent environmental concerns. The production of Biochar for carbon sequestration in the soil is a carbon-negative process.
Charles R. Shirley, CEO of Solanbridge, stated, "We are are excited to be working with Vega and selling their Biochar product in Canada, Jamaica, and South Central Asia. We believe the product will be a perfect fit for the medical marijuana markets we are currently pursuing. BioChar will complement the cultivation processes that they already have in place. We also find the BioChar product to be a perfect complement to Solanbridge's current business plan."
Michael K. Molen, Chairman/CEO of Vega Biofuels, Inc. stated, "We are happy to announce the Agreement with Solanbridge. This deal will significantly increase our marketing efforts for Biochar. With the acquisitions Solanbridge has made recently and their plans for future expansion, we feel they can have a significant impact on our bottom line by reaching markets that we are not currently marketing to."
About Solanbridge Group Inc
Solanbridge Group Inc, based in The Woodlands, Texas, is a diversified holding company looking to expand into the medical marijuana industry by developing commercial grower's licenses in Eastern Canadian medical marijuana jurisdictions, with the partnership of First Nations and developing CBD-infused products in Colorado and Nevada. Solanbridge is also pursuing other acquisitions in the growing medical marijuana field and partnerships with agribusiness entities.
This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. This presentation contains forward-looking statements that involve substantial risks and uncertainties. You can identify forward-looking statements by words such as anticipate, believe, could, estimate, expect, intend, may, plan, should, will, would or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. We believe that it is important to communicate our future expectations to our investors. There may be events in the future, however, that we are not able to predict accurately or control. Our actual results may differ materially from the expectations we describe in our forward looking statements. Factors or events that could cause our actual results to materially differ may emerge from time to time, and it is not possible for us to accurately predict all of them. Before you invest in our common stock, you should be aware that the occurrence of any such event could have a material adverse effect on our business, results of operation and financial position. Any forward-looking statement made by us in this presentation speaks only as of the date on which we make it. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Contact:
Charles R. Shirley
Solanbridge Group Inc
[email protected]
832.225.1372
SOURCE: Solanbridge Group Inc